Table 2.
Summary of available evidence on the prevalence of aspartate aminotransferase/alanine aminotransferase elevations in COVID-19 patients

Summary of available evidence on the prevalence of aspartate aminotransferase/alanine aminotransferase elevations in COVID-19 patients
